[HTML][HTML] Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention

NF Lange, P Radu, JF Dufour - Journal of hepatology, 2021 - Elsevier
In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with
non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is …

Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): Insights into the role of oxidative stress and …

G Tang, Y Xu, C Zhang, N Wang, H Li, Y Feng - Antioxidants, 2021 - mdpi.com
Nonalcoholic fatty liver diseases (NAFLD) represent a set of liver disorders progressing from
steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, which induce …

[HTML][HTML] Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease prevention

S Surma, A Sahebkar, M Banach - Pharmacological Research, 2023 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of premature death
worldwide. Inflammation and its biomarkers, like C-reactive protein (CRP), among the risk …

[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis

K Yang, J Chen, T Zhang, X Yuan, A Ge… - Frontiers in …, 2022 - frontiersin.org
Background Dietary polyphenol treatment of non-alcoholic fatty liver disease (NAFLD) is a
novel direction, and the existing clinical studies have little effective evidence for its …

Plant‐based foods and their bioactive compounds on fatty liver disease: Effects, mechanisms, and clinical application

HY Li, RY Gan, A Shang, QQ Mao… - Oxidative medicine …, 2021 - Wiley Online Library
Fatty liver disease (FLD), including nonalcoholic fatty liver disease (NAFLD) and alcoholic
fatty liver disease (AFLD), is a serious chronic metabolic disease that affects a wide range of …

Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis

SB Ding, XL Chu, YX Jin, JJ Jiang, X Zhao… - Frontiers in …, 2023 - frontiersin.org
Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic advanced liver disease
that is highly related to metabolic disorders and induced by a high-fat diet (HFD). Recently …

Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: Lessons learned from preclinical and human studies

JK Hodges, GY Sasaki, RS Bruno - The Journal of nutritional biochemistry, 2020 - Elsevier
Nonalcoholic fatty liver disease (NAFLD), which is the most prevalent hepatic disorder
worldwide, affecting 25% of the general population, describes a spectrum of progressive …

Green and white teas as health-promoting foods

D Hinojosa-Nogueira, S Pérez-Burillo… - Food & function, 2021 - pubs.rsc.org
Tea is one of the most consumed beverages around the world and as such, it is constantly
the object of novel research. This review focuses on the research performed during the last …

Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real‐time two‐dimensional …

D Soleimani, M Rezaie, F Rajabzadeh… - Phytotherapy …, 2021 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, while no
drugs have been approved for its treatment. The pieces of evidence indicate that propolis as …